![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: LRP1 |
Gene summary for LRP1 |
![]() |
Gene information | Species | Human | Gene symbol | LRP1 | Gene ID | 4035 |
Gene name | LDL receptor related protein 1 | |
Gene Alias | A2MR | |
Cytomap | 12q13.3 | |
Gene Type | protein-coding | GO ID | GO:0000165 | UniProtAcc | Q07954 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
4035 | LRP1 | CA_HPV_3 | Human | Cervix | CC | 1.24e-03 | -1.44e-02 | 0.0414 |
4035 | LRP1 | CCI_1 | Human | Cervix | CC | 2.83e-03 | 9.08e-01 | 0.528 |
4035 | LRP1 | CCI_3 | Human | Cervix | CC | 7.50e-20 | 1.34e+00 | 0.516 |
4035 | LRP1 | sample3 | Human | Cervix | CC | 7.98e-24 | 4.17e-01 | 0.1387 |
4035 | LRP1 | T3 | Human | Cervix | CC | 1.68e-13 | 4.17e-01 | 0.1389 |
4035 | LRP1 | HTA11_2487_2000001011 | Human | Colorectum | SER | 8.12e-03 | 3.26e-01 | -0.1808 |
4035 | LRP1 | HTA11_1938_2000001011 | Human | Colorectum | AD | 1.69e-05 | 3.99e-01 | -0.0811 |
4035 | LRP1 | HTA11_347_2000001011 | Human | Colorectum | AD | 3.82e-09 | 4.38e-01 | -0.1954 |
4035 | LRP1 | HTA11_411_2000001011 | Human | Colorectum | SER | 3.93e-05 | 7.58e-01 | -0.2602 |
4035 | LRP1 | HTA11_3361_2000001011 | Human | Colorectum | AD | 3.40e-03 | 3.21e-01 | -0.1207 |
4035 | LRP1 | HTA11_696_2000001011 | Human | Colorectum | AD | 1.14e-15 | 5.67e-01 | -0.1464 |
4035 | LRP1 | HTA11_866_2000001011 | Human | Colorectum | AD | 3.86e-16 | 5.03e-01 | -0.1001 |
4035 | LRP1 | HTA11_1391_2000001011 | Human | Colorectum | AD | 5.71e-09 | 5.78e-01 | -0.059 |
4035 | LRP1 | HTA11_546_2000001011 | Human | Colorectum | AD | 4.78e-06 | 5.47e-01 | -0.0842 |
4035 | LRP1 | HTA11_866_3004761011 | Human | Colorectum | AD | 1.76e-10 | 4.06e-01 | 0.096 |
4035 | LRP1 | HTA11_7696_3000711011 | Human | Colorectum | AD | 1.26e-06 | 3.56e-01 | 0.0674 |
4035 | LRP1 | HTA11_99999971662_82457 | Human | Colorectum | MSS | 8.52e-10 | 5.27e-01 | 0.3859 |
4035 | LRP1 | HTA11_99999974143_84620 | Human | Colorectum | MSS | 3.16e-05 | 3.15e-01 | 0.3005 |
4035 | LRP1 | A015-C-203 | Human | Colorectum | FAP | 1.69e-03 | 4.88e-02 | -0.1294 |
4035 | LRP1 | A002-C-021 | Human | Colorectum | FAP | 3.69e-03 | 2.68e-01 | 0.1171 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:004217610 | Cervix | CC | regulation of protein catabolic process | 104/2311 | 391/18723 | 9.39e-15 | 9.36e-12 | 104 |
GO:001081010 | Cervix | CC | regulation of cell-substrate adhesion | 69/2311 | 221/18723 | 8.57e-14 | 5.69e-11 | 69 |
GO:00315898 | Cervix | CC | cell-substrate adhesion | 96/2311 | 363/18723 | 1.48e-13 | 8.85e-11 | 96 |
GO:005254710 | Cervix | CC | regulation of peptidase activity | 112/2311 | 461/18723 | 6.70e-13 | 3.08e-10 | 112 |
GO:190336210 | Cervix | CC | regulation of cellular protein catabolic process | 72/2311 | 255/18723 | 5.98e-12 | 2.10e-09 | 72 |
GO:003297010 | Cervix | CC | regulation of actin filament-based process | 96/2311 | 397/18723 | 4.00e-11 | 8.54e-09 | 96 |
GO:004573210 | Cervix | CC | positive regulation of protein catabolic process | 65/2311 | 231/18723 | 7.44e-11 | 1.39e-08 | 65 |
GO:190382910 | Cervix | CC | positive regulation of cellular protein localization | 72/2311 | 276/18723 | 3.20e-10 | 4.46e-08 | 72 |
GO:01501159 | Cervix | CC | cell-substrate junction organization | 37/2311 | 101/18723 | 3.20e-10 | 4.46e-08 | 37 |
GO:007265910 | Cervix | CC | protein localization to plasma membrane | 73/2311 | 284/18723 | 4.95e-10 | 6.73e-08 | 73 |
GO:000989610 | Cervix | CC | positive regulation of catabolic process | 109/2311 | 492/18723 | 5.26e-10 | 6.99e-08 | 109 |
GO:003295610 | Cervix | CC | regulation of actin cytoskeleton organization | 86/2311 | 358/18723 | 5.90e-10 | 7.51e-08 | 86 |
GO:00070448 | Cervix | CC | cell-substrate junction assembly | 34/2311 | 95/18723 | 3.35e-09 | 3.45e-07 | 34 |
GO:00160557 | Cervix | CC | Wnt signaling pathway | 98/2311 | 444/18723 | 4.82e-09 | 4.65e-07 | 98 |
GO:00321035 | Cervix | CC | positive regulation of response to external stimulus | 95/2311 | 427/18723 | 5.44e-09 | 5.03e-07 | 95 |
GO:01987387 | Cervix | CC | cell-cell signaling by wnt | 98/2311 | 446/18723 | 6.16e-09 | 5.58e-07 | 98 |
GO:19907788 | Cervix | CC | protein localization to cell periphery | 78/2311 | 333/18723 | 1.22e-08 | 9.73e-07 | 78 |
GO:00019528 | Cervix | CC | regulation of cell-matrix adhesion | 40/2311 | 128/18723 | 1.32e-08 | 1.04e-06 | 40 |
GO:00071608 | Cervix | CC | cell-matrix adhesion | 60/2311 | 233/18723 | 1.58e-08 | 1.23e-06 | 60 |
GO:00071626 | Cervix | CC | negative regulation of cell adhesion | 72/2311 | 303/18723 | 2.36e-08 | 1.70e-06 | 72 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0501018 | Cervix | CC | Alzheimer disease | 113/1267 | 384/8465 | 9.67e-14 | 3.92e-12 | 2.32e-12 | 113 |
hsa0501019 | Cervix | CC | Alzheimer disease | 113/1267 | 384/8465 | 9.67e-14 | 3.92e-12 | 2.32e-12 | 113 |
hsa05010 | Colorectum | AD | Alzheimer disease | 174/2092 | 384/8465 | 1.82e-19 | 9.26e-18 | 5.91e-18 | 174 |
hsa050101 | Colorectum | AD | Alzheimer disease | 174/2092 | 384/8465 | 1.82e-19 | 9.26e-18 | 5.91e-18 | 174 |
hsa050102 | Colorectum | SER | Alzheimer disease | 146/1580 | 384/8465 | 6.52e-20 | 2.40e-18 | 1.75e-18 | 146 |
hsa050103 | Colorectum | SER | Alzheimer disease | 146/1580 | 384/8465 | 6.52e-20 | 2.40e-18 | 1.75e-18 | 146 |
hsa050104 | Colorectum | MSS | Alzheimer disease | 169/1875 | 384/8465 | 1.21e-22 | 1.01e-20 | 6.21e-21 | 169 |
hsa050105 | Colorectum | MSS | Alzheimer disease | 169/1875 | 384/8465 | 1.21e-22 | 1.01e-20 | 6.21e-21 | 169 |
hsa050108 | Colorectum | FAP | Alzheimer disease | 105/1404 | 384/8465 | 3.74e-08 | 1.04e-06 | 6.33e-07 | 105 |
hsa050109 | Colorectum | FAP | Alzheimer disease | 105/1404 | 384/8465 | 3.74e-08 | 1.04e-06 | 6.33e-07 | 105 |
hsa05010210 | Esophagus | ESCC | Alzheimer disease | 263/4205 | 384/8465 | 1.80e-14 | 5.47e-13 | 2.80e-13 | 263 |
hsa0501038 | Esophagus | ESCC | Alzheimer disease | 263/4205 | 384/8465 | 1.80e-14 | 5.47e-13 | 2.80e-13 | 263 |
hsa049796 | Liver | NAFLD | Cholesterol metabolism | 20/1043 | 51/8465 | 9.73e-07 | 4.56e-05 | 3.67e-05 | 20 |
hsa0497911 | Liver | NAFLD | Cholesterol metabolism | 20/1043 | 51/8465 | 9.73e-07 | 4.56e-05 | 3.67e-05 | 20 |
hsa0501014 | Liver | Cirrhotic | Alzheimer disease | 180/2530 | 384/8465 | 5.52e-13 | 1.36e-11 | 8.36e-12 | 180 |
hsa049792 | Liver | Cirrhotic | Cholesterol metabolism | 30/2530 | 51/8465 | 1.59e-05 | 1.39e-04 | 8.60e-05 | 30 |
hsa0501015 | Liver | Cirrhotic | Alzheimer disease | 180/2530 | 384/8465 | 5.52e-13 | 1.36e-11 | 8.36e-12 | 180 |
hsa049793 | Liver | Cirrhotic | Cholesterol metabolism | 30/2530 | 51/8465 | 1.59e-05 | 1.39e-04 | 8.60e-05 | 30 |
hsa0501022 | Liver | HCC | Alzheimer disease | 254/4020 | 384/8465 | 3.75e-14 | 8.97e-13 | 4.99e-13 | 254 |
hsa049794 | Liver | HCC | Cholesterol metabolism | 41/4020 | 51/8465 | 1.33e-06 | 1.35e-05 | 7.49e-06 | 41 |
Page: 1 2 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
MDK | LRP1 | MDK_LRP1 | MK | Breast | DCIS |
MDK | LRP1 | MDK_LRP1 | MK | Breast | Healthy |
MDK | LRP1 | MDK_LRP1 | MK | Breast | IDC |
MDK | LRP1 | MDK_LRP1 | MK | Breast | Precancer |
MDK | LRP1 | MDK_LRP1 | MK | Cervix | ADJ |
MDK | LRP1 | MDK_LRP1 | MK | Cervix | CC |
MDK | LRP1 | MDK_LRP1 | MK | Cervix | Healthy |
MDK | LRP1 | MDK_LRP1 | MK | Cervix | Precancer |
MDK | LRP1 | MDK_LRP1 | MK | CRC | AD |
MDK | LRP1 | MDK_LRP1 | MK | CRC | ADJ |
MDK | LRP1 | MDK_LRP1 | MK | CRC | MSI-H |
MDK | LRP1 | MDK_LRP1 | MK | CRC | MSS |
MDK | LRP1 | MDK_LRP1 | MK | CRC | SER |
MDK | LRP1 | MDK_LRP1 | MK | Endometrium | ADJ |
MDK | LRP1 | MDK_LRP1 | MK | Endometrium | AEH |
MDK | LRP1 | MDK_LRP1 | MK | Endometrium | EEC |
MDK | LRP1 | MDK_LRP1 | MK | Endometrium | Healthy |
MDK | LRP1 | MDK_LRP1 | MK | Esophagus | ESCC |
MDK | LRP1 | MDK_LRP1 | MK | Esophagus | Healthy |
MDK | LRP1 | MDK_LRP1 | MK | GC | ADJ |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
LRP1 | SNV | Missense_Mutation | novel | c.2357G>C | p.Arg786Pro | p.R786P | Q07954 | protein_coding | deleterious(0.01) | probably_damaging(0.989) | TCGA-96-A4JK-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Chemotherapy | gemcitabine | CR |
LRP1 | SNV | Missense_Mutation | novel | c.11853C>G | p.His3951Gln | p.H3951Q | Q07954 | protein_coding | tolerated(0.6) | benign(0.031) | TCGA-98-8021-01 | Lung | lung squamous cell carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
LRP1 | SNV | Missense_Mutation | c.6617N>A | p.Arg2206His | p.R2206H | Q07954 | protein_coding | deleterious(0.01) | probably_damaging(0.987) | TCGA-NC-A5HH-01 | Lung | lung squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
LRP1 | insertion | Frame_Shift_Ins | novel | c.11202dupC | p.Thr3735HisfsTer32 | p.T3735Hfs*32 | Q07954 | protein_coding | TCGA-95-7567-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Chemotherapy | cisplatin | SD | ||
LRP1 | SNV | Missense_Mutation | novel | c.1844N>G | p.Asn615Ser | p.N615S | Q07954 | protein_coding | deleterious(0.01) | probably_damaging(0.989) | TCGA-BA-A6D8-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Chemotherapy | cisplatin | PD |
LRP1 | SNV | Missense_Mutation | rs768155333 | c.802N>A | p.Val268Met | p.V268M | Q07954 | protein_coding | tolerated(0.07) | benign(0.288) | TCGA-BB-A5HY-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Chemotherapy | cisplatin | PD |
LRP1 | SNV | Missense_Mutation | novel | c.11864N>T | p.Ser3955Leu | p.S3955L | Q07954 | protein_coding | tolerated(0.21) | benign(0.037) | TCGA-CN-4723-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
LRP1 | SNV | Missense_Mutation | rs144804370 | c.5875N>T | p.Val1959Leu | p.V1959L | Q07954 | protein_coding | deleterious(0.03) | benign(0.15) | TCGA-CN-4738-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
LRP1 | SNV | Missense_Mutation | novel | c.4400G>A | p.Gly1467Asp | p.G1467D | Q07954 | protein_coding | tolerated(0.2) | probably_damaging(0.999) | TCGA-CN-5360-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | I/II | Chemotherapy | cisplatin | SD |
LRP1 | SNV | Missense_Mutation | c.5687C>A | p.Ser1896Tyr | p.S1896Y | Q07954 | protein_coding | deleterious(0) | probably_damaging(0.986) | TCGA-CN-6010-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Chemotherapy | cisplatin | PD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
4035 | LRP1 | KINASE, DRUGGABLE GENOME | ANTISENSE OLIGONUCLEOTIDES | 11095961 |
Page: 1 |